NOVOCURE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.90 USD | +1.75% |
|
+0.90% | +13.19% |
| 09-03 | NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor | MT |
| 09-03 | Novocure Announces CEO Changes, Effective January 1, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical Equipment
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.83B | - | |||||
| 12.57B | - | - | - | - | - | |
| 7.93B | ||||||
| 6.15B | - | - | ||||
| 5.75B | ||||||
| 5.22B |
- Stock Market
- Equities
- NVCR Stock
- Charts NovoCure Limited
- Sector Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition